Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine and Riluzole in ALS (TAME)
NCT01020331Phase 2Completed
- Sponsor
- Phoenix Neurological Associates
- Start
- Jun 2005
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of memantine in amyotrophic lateral sclerosis (ALS), sponsored by Phoenix Neurological Associates. Started Jun 2005; status: completed.
02
Drugs
memantine
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT01020331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01020331.